John P. Schmid Buys $96K of BlossomHill Therapeutics Inc (BLSM) — SEC Form 4, Aug 10, 2026
Open-Market Net Purchase · SEC Form 4
+$96,000
Equity Position
6K sh
0 → 6,000
Filing Lag
0 business days
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| John P. Schmid CIK 0001478916 |
Director
|
John P. Schmid at BlossomHill Therapeutics Inc
Full insider history
Bought (12 mo)
$96,000
Sold (12 mo)
—
Non-Derivative Securities Transactions
| Title | Date | Type | Shares | Price | Net Total | Post-Txn | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-08-10 | P - Purchase | 6,000 A | $16.00 | +$96,000 | 6,000 | Direct |
Related filings at BlossomHill Therapeutics Inc
5%+ Holders · 13D/G
4 filers
Other insiders at BlossomHill Therapeutics Inc
-
Carl L Gordon +$10M
-
Orbimed Advisors LLC +$10M
-
Bihua Chen +$5M
-
Jason A Keyes +$11.2K
GET /v1/forms/4/0001478916-26-000015
API docs
View Original SEC Filing